Lifetime Benefits for Budesonide/Glycopyrrolate/Formoterol Fumarate versus Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist and Inhaled Corticosteroid/Long-Acting β 2 -Agonist Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease [PDF]
, 2021 Enrico De Nigris +5 more
openalex +1 more source
The effect of inhaled extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide on distal and central airway indices, assessed using Functional Respiratory Imaging in COPD (DARWiIN). [PDF]
Respir Res, 2023 Skloot GS +8 more
europepmc +1 more source
Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD [PDF]
, 2020 Wilfried De Backer +12 more
openalex +1 more source
International Journal of COPD, 2016 Maria Gabriella Matera,1 Alessandro Sanduzzi,2 Mario Cazzola3 1Department of Experimental Medicine, Second University of Naples, 2Department of Respiratory Diseases, Monaldi Hospital, University Federico II, Naples, 3Department of Systems Medicine ...
Matera MG, Sanduzzi A, Cazzola M
doaj
SIMULTANEOUS ESTIMATION OF MOMETASONE FUROATE AND FORMOTEROL FUMARATE BY HPLC METHOD IN ROTACAPS
, 2018 Aarti S. Zanwar +3 more
openalex +2 more sources
Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease. [PDF]
Ther Adv Respir Dis, 2023 Pelaia C +8 more
europepmc +1 more source